Prelude Therapeutics, Inc. (PRLD)
3.75
-0.14
(-3.60%)
USD |
NASDAQ |
Oct 12, 15:54
Prelude Therapeutics EPS Diluted (Quarterly) : -0.1415 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1415 |
| March 31, 2026 | -0.1258 |
| December 31, 2025 | -0.2614 |
| September 30, 2025 | -0.2591 |
| June 30, 2025 | -0.411 |
| March 31, 2025 | -0.4222 |
| December 31, 2024 | -0.521 |
| September 30, 2024 | -0.4254 |
| June 30, 2024 | -0.4585 |
| March 31, 2024 | -0.415 |
| December 31, 2023 | -0.6023 |
| September 30, 2023 | -0.4525 |
| June 30, 2023 | -0.5411 |
| March 31, 2023 | -0.5806 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.598 |
| September 30, 2022 | -0.6314 |
| June 30, 2022 | -0.579 |
| March 31, 2022 | -0.626 |
| December 31, 2021 | -0.6899 |
| September 30, 2021 | -0.6503 |
| June 30, 2021 | -0.5711 |
| March 31, 2021 | -0.4552 |
| December 31, 2020 | -0.4404 |
| September 30, 2020 | -0.3835 |
| June 30, 2020 | -0.261 |
| March 31, 2020 | -0.2176 |
| December 31, 2019 | -0.2297 |
| September 30, 2019 | -0.1541 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Q32 Bio, Inc. | -0.4398 |
| Intellia Therapeutics, Inc. | -0.7989 |
| Twist Bioscience Corp. | -0.5617 |
| Beam Therapeutics, Inc. | -1.176 |
| Revolution Medicines, Inc. | -3.055 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.92M |
| Revenue (Quarterly) | 5.704M |
| Total Expenses (Quarterly) | 19.62M |
| Enterprise Value | 176.15M |
| Gross Profit Margin (Quarterly) | 93.81% |
| Profit Margin (Quarterly) | -244.1% |
| Earnings Yield | -21.01% |
| Normalized Earnings Yield | -21.01 |